These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 14725687)

  • 1. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
    Gambineri A; Pelusi C; Genghini S; Morselli-Labate AM; Cacciari M; Pagotto U; Pasquali R
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):241-9. PubMed ID: 14725687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.
    Gambineri A; Patton L; Vaccina A; Cacciari M; Morselli-Labate AM; Cavazza C; Pagotto U; Pasquali R
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3970-80. PubMed ID: 16868063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for hirsutism (excluding laser and photoepilation therapy alone).
    van Zuuren EJ; Fedorowicz Z; Carter B; Pandis N
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010334. PubMed ID: 25918921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome.
    Ibáñez L; de Zegher F
    Hum Reprod; 2003 Jan; 18(1):57-60. PubMed ID: 12525441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.
    Ibáñez L; Valls C; Ferrer A; Ong K; Dunger DB; De Zegher F
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2870-4. PubMed ID: 12050266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
    Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
    Ibáñez L; de Zegher F
    Hum Reprod Update; 2006; 12(3):243-52. PubMed ID: 16407452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of 6-month treatment with oral antiandrogen alone and in combination with insulin sensitizers on body composition, hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS) in order to determine therapeutic strategy].
    Orbetsova M; Kamenov Z; Kolarov G; Zakharieva S; Khristov V; Atanasova I; Shigarminova R; Milcheva B; Genchev G
    Akush Ginekol (Sofiia); 2006; 45(7):16-28. PubMed ID: 17489164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome.
    Gambineri A; Pagotto U; Tschöp M; Vicennati V; Manicardi E; Carcello A; Cacciari M; De Iasio R; Pasquali R
    J Endocrinol Invest; 2003 Jul; 26(7):629-34. PubMed ID: 14594113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome.
    Esfahanian F; Zamani MM; Heshmat R; Moini nia F
    J Obstet Gynaecol Res; 2013 Apr; 39(4):806-13. PubMed ID: 23279603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study.
    Sahin I; Serter R; Karakurt F; Demirbas B; Culha C; Taskapan C; Kosar F; Aral Y
    Gynecol Endocrinol; 2004 Sep; 19(3):115-24. PubMed ID: 15697072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin.
    Glueck CJ; Moreira A; Goldenberg N; Sieve L; Wang P
    Hum Reprod; 2003 Aug; 18(8):1618-25. PubMed ID: 12871871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Unlühizarci K; Keleştimur F; Bayram F; Sahin Y; Tutuş A
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.
    Diamanti-Kandarakis E; Mitrakou A; Raptis S; Tolis G; Duleba AJ
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2699-705. PubMed ID: 9709934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome.
    Kowalska I; Kinalski M; Straczkowski M; Wolczyski S; Kinalska I
    Eur J Endocrinol; 2001 May; 144(5):509-15. PubMed ID: 11331217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.
    Mehrabani HH; Salehpour S; Amiri Z; Farahani SJ; Meyer BJ; Tahbaz F
    J Am Coll Nutr; 2012 Apr; 31(2):117-25. PubMed ID: 22855917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.
    Ibáñez L; De Zegher F
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4720-4. PubMed ID: 14557446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen LC; Vauhkonen I; Koivunen RM; Ruokonen A; Martikainen HK; Tapanainen JS
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3161-8. PubMed ID: 10999803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.